Tag: Enfortumab vedotin

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Enfortumab vedotin

Seattle Genetics (SGEN) Q4 Earnings Top, Adcetris Drives Sales

Added to Collection on: 2020-02-07 01:12:31

Tags for this article:

Clinical medicine
Medicine
Health care
Breakthrough therapy
Antineoplastic drugs
Cancer treatments
Orphan drugs
Cancer immunotherapy
Seagen
Tucatinib
Enfortumab vedotin
Pembrolizumab
Seattle Genetics Inc.

Click the tags to see associated articles and topics

View Article Details
Roche joins the FDA accelerated approval revamp team, nixing a Tecentriq bladder cancer nod

Added to Collection on: 2021-03-08 13:53:23

Tags for this article:

Clinical medicine
Cancer treatments
Medicine
Breakthrough therapy
Orphan drugs
Cancer immunotherapy
Antineoplastic drugs
Monoclonal antibodies
Atezolizumab
Pembrolizumab
PD-1 and PD-L1 inhibitors
Enfortumab vedotin

Click the tags to see associated articles and topics

View Article Details
Discoveries & Impact (March 2021)

Added to Collection on: 2021-03-11 18:55:33

Tags for this article:

Breakthrough therapy
Cancer immunotherapy
Enfortumab vedotin
Clinical medicine
Medicine

Click the tags to see associated articles and topics

View Article Details
Seagen Earnings: Strong Sales Growth and Pipeline Makes Progress; Acquisition by Pfizer on Track

Added to Collection on: 2023-11-09 19:42:59

Tags for this article:

Breakthrough therapy
Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Antibody-drug conjugates
Seagen
Antibody-drug conjugate
Pembrolizumab
Transitional cell carcinoma
Enfortumab vedotin
Brentuximab vedotin
Chemotherapy
Padcev

Click the tags to see associated articles and topics

View Article Details
FDA Approves PADCEV, KEYTRUDA Combo as First ADC, PD-1 Bladder Cancer Treatment

Added to Collection on: 2023-12-16 11:47:02

Tags for this article:

Antineoplastic drugs
Breakthrough therapy
Orphan drugs
Cancer immunotherapy
Pembrolizumab
Cancer treatments
Transitional cell carcinoma
Bladder cancer
Enfortumab vedotin
Chemotherapy
Head and neck cancer
Antibody-drug conjugate
Astellas Pharma Inc.
Pfizer Inc.
Cisplatin
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
FDA approves Keytruda/Padcev combo therapy for bladder cancer - Seeking Alpha

Added to Collection on: 2023-12-15 23:21:17

Tags for this article:

Breakthrough therapy
Cancer immunotherapy
Orphan drugs
Antineoplastic drugs
Immune system
Pembrolizumab
Seagen
Pfizer
Programmed cell death protein 1
Astellas Pharma
Enfortumab vedotin
Transitional cell carcinoma
Merck

Click the tags to see associated articles and topics

View Article Details
Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization ... - Yahoo Finance

Added to Collection on: 2024-03-01 20:37:42

Tags for this article:

Antineoplastic drugs
Cancer immunotherapy
Seagen
Biotechnology
Pfizer
Antibody-drug conjugate
Oncology
Enfortumab vedotin
Pembrolizumab
Pfizer Inc.

Click the tags to see associated articles and topics

View Article Details
Many Patients With Advanced Urothelial Cancer Are Not Receiving Second-Line Therapy

Added to Collection on: 2024-05-07 15:43:55

Tags for this article:

Cancer treatments
Cancer immunotherapy
Antibody-drug conjugates
Antineoplastic drugs
Orphan drugs
Enfortumab vedotin
Erdafitinib
Transitional cell carcinoma
Chemotherapy
Sacituzumab govitecan
PD-1 and PD-L1 inhibitors
Cisplatin
Flatiron Health

Click the tags to see associated articles and topics

View Article Details
Positive OS for Bladder Cancer Combo, Biomarkers on Tap at ASCO GU 2025

Added to Collection on: 2025-02-11 20:28:07

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Cancer treatments
Antibody-drug conjugates
Pembrolizumab
Enfortumab vedotin
Nivolumab
Bladder cancer
Antibody-drug conjugate
Transitional cell carcinoma
Ipilimumab

Click the tags to see associated articles and topics

View Article Details
Early On-Treatment Weight Loss Linked to Worse OS in Urothelial Carcinoma

Added to Collection on: 2025-08-27 18:38:22

Tags for this article:

Cancer immunotherapy
Antibody-drug conjugates
Orphan drugs
Antineoplastic drugs
Enfortumab vedotin
Transitional cell carcinoma
Pembrolizumab
Transitional epithelium
Monomethyl auristatin E
Disitamab vedotin
Flatiron Health

Click the tags to see associated articles and topics

View Article Details
Book a Demo